Screener
Pulse Biosciences, Inc. PLSE Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expense): | ||||
| Interest income | 600 | 1,129 | 1,193 | 2,384 |
| Other income (expense) | 15 | (22) | (9) | (28) |
| Total other income | 615 | 1,107 | 1,184 | 2,356 |
| Net loss | (24,657) | (19,168) | (43,238) | (35,963) |
| Comprehensive loss | $(24,657) | $(19,168) | $(43,238) | $(35,963) |
| Net loss per share, basic and diluted | $(0.36) | $(0.28) | $(0.63) | $(0.54) |
| Weighted average common shares outstanding, basic and diluted | 69,200,020 | 67,275,608 | 68,600,623 | 67,201,198 |
Document
FAQ
- What is Pulse Biosciences, Inc.'s net income?
- Pulse Biosciences, Inc. (PLSE) reported net income of -$24.66M in Q2 2026.
- How has Pulse Biosciences, Inc.'s net income changed year-over-year?
- Pulse Biosciences, Inc.'s net income decreased by 28.6% year-over-year, from -$19.17M to -$24.66M.
- What is the long-term trend for Pulse Biosciences, Inc.'s net income?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s net income has grown at a 3.4% compound annual growth rate (CAGR), from -$63.66M to -$72.78M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Pulse Biosciences, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude